NCT00235118已完成1 期
An Evaluation of the Safety and Effectiveness of the Cordis Bilateral AAA Device Compared to Open Surgical Repair for the Treatment of Abdominal Aortic Aneurysm
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 29
- 试验地点
- 1
- 主要终点
- Primary success is defined as freedom from all of the following: rupture of aneurysm, enlargement of aneurysm > 0.5 cm on CT scan, with or without endoleak, as compared to any previous measurement, symptomatic aneurysm requiring treatment.
研究概览
简要总结
The objective of this study is to assess the safety and effectiveness of the Cordis Bilateral AAA device and its Delivery System compared to open surgical repair for the treatment of Abdominal Aortic Aneurysm (AAA).
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •- Anatomic (stent-graft)
- •Aortic Aneurysm Diameter
- •> 4.5 cm
- •Those aortic aneurysms < 4.5 cm that are at least 1.5 times the diameter of the aorta with a size increase of 5 mm or greater over a six month period will also be included for possible treatment.
- •Aorto-iliac aneurysms in which the aortic aneurysm is < 4.5 cm but the iliac artery aneurysms are > 3.0 cm in diameter or there is evidence of recent expansion (5 mm or greater over a six month period) in iliac aneurysms < 3.0 cm.
- •Saccular aortic aneurysms > 3.0 cm.
- •Aortic Neck
- •Diameter > 17 mm and < 28 mm (Phase I)
- •Diameter > 14 mm and < 28 mm (Phase II)
- •Angulation Neck Length < 45° > 15 mm <60° > 25 mm
- •Iliac Arteries
- •Diameter > 8 mm and < 18 mm (Phase I and Phase II)
- •At least one common iliac artery with a cuff > 15 mm.
- •Diameter Aortic Neck Common Iliac 26-28 mm 13-18 mm 23-25.9 mm 10-17 mm 20-22.9 mm 9-15 mm 17-19.9 mm 8-13 mm 14-16.9 mm 8-11mm
- •*NOTE: An aortic diameter cannot be treated if the iliac diameter is not in the same range (e.g. 26-28 mm aortic necks must be in conjunction with 13-18 mm common iliacs).
- •Anatomic (surgical controls)
- •· Surgical controls will be required to meet only the aortic or aorto-iliac aneurysm size requirements for anatomic inclusion criteria.
- •Aortic Aneurysm Diameter
- •> 4.5 cm
- •Those aortic aneurysms <4.5 cm that are at least 1.5 times the diameter of the aorta with a size increase of 5 mm or greater over a six month period will also be included for possible treatment.
- •Aorto-iliac aneurysm in which the aortic aneurysm is <4.5 cm but the iliac artery aneurysm are >3.0 cm in diameter or there is evidence of recent expansion (5 mm or greater over a six month period) in iliac aneurysms <3.0 cm.
- •Saccular aortic aneurysms > 3.0 cm.
- •Clinical (stent-graft)
- •Males and non-pregnant females > 40 years of age.
- •Clinical (surgical controls)
- •Surgical control patients will be required to meet all of the above-stated stent-graft clinical inclusion criteria.
排除标准
- •Anatomic (stent-graft)
- •Aortic Aneurysm Diameter
- •· < 4.5 cm that are not at least 1.5 times the diameter of the aorta with evidence of a size increase of 5 mm or greater within a six month period.
- •Aorto-iliac Aneurysms
- •< 3.0 cm in diameter unless evidence of recent expansion (5 mm or greater within a six month period).
- •The iliac portion of the aneurysm extending to the bifurcation bilaterally which would necessitate covering both internal iliac arteries with the device.
- •Aortic Neck
- •Diameter < 17 mm and > 28 mm (Phase I)
- •Diameter < 14 and >28 (Phase II)
- •Thrombus lined
- •Highly calcified
- •NOTE: See inclusion criteria for length below the renals and degree of angulation.
- •Iliac Arteries
- •< 8 mm and > 18 mm (native) (Phase I and Phase II)
- •Highly calcified (common)
- •Neither common iliac artery with a cuff > 15 mm.
- •NOTE: See inclusion criteria for aortic neck and iliac artery diameters.
- •Anatomic (surgical controls)
- •· Surgical controls will be excluded based only on the aortic or aorto-iliac aneurysm size requirements for anatomic exclusion criteria.
- •Aortic Aneurysm Diameter
- •· < 4.5 cm that are not at least 1.5 times the diameter of the aorta with evidence of a size increase of 5 mm or greater within a six month period.
- •Aorto-Iliac Aneurysms
- •< 3.0 cm in diameter unless evidence of recent expansion (5 mm or greater within a six month period).
- •The iliac portion of the aneurysm extending to the bifurcation bilaterally which would necessitate surgically covering both internal iliac arteries.
- •Clinical (stent-graft)
- •Ruptured abdominal aortic aneurysm.
- •Renal insufficiency - creatinine level > 2.5 mg/dl.
结局指标
主要结局
Primary success is defined as freedom from all of the following: rupture of aneurysm, enlargement of aneurysm > 0.5 cm on CT scan, with or without endoleak, as compared to any previous measurement, symptomatic aneurysm requiring treatment.
The absence of major complications at thirty days defined as arterial thrombosis, respiratory impairment, renal failure, myocardial infarction (M.I.) and stroke in combination with the absence of major complications at one year.
次要结局
- · Technical success defined as the successful access and deployment of the device at the appropriate anatomic location with aneurysmal exclusion determined by angiography at the time of deployment.
- ·
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Bronchoscopic Microwave Ablation of Lung Tissue in Surgical CandidatesLung CancerNCT06689488Creo Medical Limited30
已完成
不适用
A Feasibility Study on the Safety and Preliminary Efficacy of Bilateral Subthalamotomy Using MRgFUS for Treatment of PDParkinson DiseaseNeurologic ManifestationsNCT03964272InSightec6
已完成
不适用
Evaluation of the Performance and Safety of the Atoldys/ Lexilens Glasses Developed to Improve the Reading of Dyslexic SubjectsDyslexiaNCT04586621ABEYE41
已完成
3 期
Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of AgeInfluenzaNCT00128167MedImmune LLC8,500
撤回
不适用
Safety and Effectiveness of Blood-Brain Barrier Disruption (BBBD) in Subjects With Suspected Infiltrating GliomaGliomaNCT04667715InSightec120